Cell-Based Assay Market worth $14.8 Billion by 2018

DALLAS, May 7, 2014 /PRNewswire/ --

According to new market research report the "Cell-Based Assays Market by Product (Reagents & Assay Kits (Cytotoxicity, GPCR), Cell lines, Plate Readers, HCS, HTS, Software & Assay Development Services), Application (Drug Discovery, ADMET), End-user (Pharmaceutical, CRO) - Global Forecast to 2018", published by MarketsandMarkets, The global Cell-Based Assay Market is poised to reach $14.8 Billion by 2018, at a CAGR of 11.1%.

Browse 88 Market Data Tables and 19 Figures spread through 243 Pages and in-depth TOC on "Cell-Based Assays Market"

http://www.marketsandmarkets.com/Market-Reports/cell-based-assays-market-119917269.html

Early buyers will receive 10% customization on this report.

This report studies the global cell-based assays market over the forecast period of 2013 to 2018.

The major market propellants for cell-based assays are benefits of cell-based assays over biochemical assays and animal models and public-private partnerships for drug discovery. The growth market is also driven by continuous innovations and developments in the market aimed at higher throughput.

The opportunities for the growth of this market include developments in emerging markets such as Asia, introduction of technologically advanced products, and increase need of toxicity screening. However, factors such as intellectual property rights are restricting innovation in the market and hence hindering growth. The optimization of assay for cell-based assay is still a challenge while complexity of HTS assays and assay standardization and validation is still an unmet need. However, some revolutionary platforms like label-free technology, 3D assays, induced pluripotent stem cells are expected to gain traction in future.

This research report categorizes and analyzes the global Cell-Based Assay Market on the basis of products, applications, end-users and geography in the cell-based assay market. All these markets are further divided into segments and sub-segments, to provide exhaustive value analysis for the years 2011, 2012, 2013, and forecast to 2018. Based on the cell-based assay product type, consumables (assay kits, reagents, microplates, cell lines), detection and screening instruments, automation and high throughput screening instruments, software and services form the overall cell-based assay market. Under applications market for cell-based assay drug discovery, ADME studies, predictive toxicology and basic research are covered. The end-users market covers academic and government institutions, pharmaceutical and biotechnology companies, and contract research organizations. 

North America accounted for the largest market share of the cell-based assay market, followed by Europe, in 2013. However, Asia presents significant opportunities for investors as the developed markets get saturated.

The major players included in this report are BD Biosciences (U.S.) , Danaher Corporation (U.S.), DiscoveRx (U.S.), EMD Millipore (Germany), GE Healthcare (U.K.), Life Technologies Corporation (U.S.), PerkinElmer (U.S.), and Promega Corporation (U.S.).

 Browse related reports 

High Throughput Screening (HTS) Market by Technology (Cell Based, Ultra High Throughput Screening (UHTS), Label Free, Bioinformatics), by Applications (Target Identification, Primary Screening, Toxicology, Stem Cell) & by End Users (Pharmaceutical Industry, Biotechnology Industry, CRO) - Forecast to 2018.

http://www.marketsandmarkets.com/Market-Reports/high-throughput-screening-market-134981950.html

 Cell Analysis Market by Instruments (Flow Cytometer, Microscope, Microfluidics, QPCR), Consumables, Application (Cell Identification, Cell Viability, Cell Proliferation, Cytology, Signal Transduction, Single Cell Analysis) - Global Forecast to 2018

http://www.marketsandmarkets.com/Market-Reports/cell-analysis-market-157543946.html

About MarketsandMarkets  

MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.

MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers thirteen industry verticals, including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, healthcare IT semiconductor and electronics, and telecommunications and IT.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Contact:
Mr. Rohan
North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas, TX 75252
Tel: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit MarketsandMarkets Blog http://www.marketsandmarketsblog.com/market-reports/healthcare/biotechnology
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets